On Monday, Cabaletta Bio Inc (NASDAQ: CABA) opened higher 4.10% from the last session, before settling in for the closing price of $2.08. Price fluctuations for CABA have ranged from $1.76 to $26.35 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -41.74% at the time writing. With a float of $41.37 million, this company’s outstanding shares have now reached $48.85 million.
In an organization with 103 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 71.2%, operating margin of -2855.41%, and the pretax margin is -2597.61%.
Cabaletta Bio Inc (CABA) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Cabaletta Bio Inc is 15.36%, while institutional ownership is 75.75%. The most recent insider transaction that took place on Jan 19 ’24, was worth 215,439. In this transaction an insider of this company sold 11,000 shares at a rate of $19.59, taking the stock ownership to the 20,000 shares.
Cabaletta Bio Inc (CABA) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.67 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -41.74% per share during the next fiscal year.
Cabaletta Bio Inc (NASDAQ: CABA) Trading Performance Indicators
Check out the current performance indicators for Cabaletta Bio Inc (CABA). In the past quarter, the stock posted a quick ratio of 8.11.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.16, a number that is poised to hit -0.64 in the next quarter and is forecasted to reach -2.54 in one year’s time.
Technical Analysis of Cabaletta Bio Inc (CABA)
Let’s dig in a bit further. During the last 5-days, its volume was 1.72 million. That was better than the volume of 1.59 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 18.04%. Additionally, its Average True Range was 0.32.
During the past 100 days, Cabaletta Bio Inc’s (CABA) raw stochastic average was set at 8.89%, which indicates a significant decrease from 23.37% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 104.29% in the past 14 days, which was lower than the 124.38% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.02, while its 200-day Moving Average is $7.09. However, in the short run, Cabaletta Bio Inc’s stock first resistance to watch stands at $2.24. Second resistance stands at $2.32. The third major resistance level sits at $2.47. If the price goes on to break the first support level at $2.01, it is likely to go to the next support level at $1.86. Assuming the price breaks the second support level, the third support level stands at $1.78.
Cabaletta Bio Inc (NASDAQ: CABA) Key Stats
There are currently 48,877K shares outstanding in the company with a market cap of 105.57 million. Presently, the company’s annual sales total 0 K according to its annual income of -67,680 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -30,630 K.
